News and events

09.05.2009 X-Rays Help Predict Permanent Bone Damage From Bisphosphonates

Breast cancer patients, individuals at risk for osteoporosis and those undergoing certain types of bone cancer therapies often take drugs containing b... read more

08.05.2009 Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research At AACR

Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel cancer metabolism drugs, highlights the breadth... read more

07.05.2009 Burzynski Research Institute Announces Positive Results Of Phase II ANP Clinical Trial

The Burzynski Research Institute (BRI) announced positive safety and efficacy results in its Phase II clinical trial of Antineoplaston A10 and Antineo... read more

06.05.2009 FDA Grants Accelerated Approval Of Avastin For Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy

Genentech, Inc. announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Avastinᢠ(bevacizumab) for people with gli... read more

05.05.2009 EFPIA Response To The A (H1N1) Novel Influenza Virus

EFPIA is aware and concerned by the current outbreak of a novel influenza, which appears to have originated in Mexico. We note the WHO's decision to ... read more

05.05.2009 Gold Nanorods Could Detect, Treat Cancer

It has long been known that heat is an effective weapon against tumor cells. However, it's difficult to heat patients' tumors without damaging nearb... read more

04.05.2009 Women More Vulnerable To Tobacco Carcinogens, New Results Show

Women may be more vulnerable than men to the cancer-causing effects of smoking tobacco, according to new results reported this week at the European Mu... read more

03.05.2009 Finding Will Improve Accuracy Of Cancer Diagnosis

Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney ... read more

02.05.2009 Novartis Investigational Adjuvanted (MF59) Pre-pandemic Avian Influenza Vaccine AflunovᢠShows Long Lasting, cross-protective Immune Response

A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunová¢, the Novartis ... read more

02.05.2009 Where Tumor Cells Boldly Go: Cancer Biologists Shed Light On The Metastatic Niche

Traditionally, cancer biologists have embraced a simple and direct model of the disease process: The tumor -- the "seed" -- was seen as bearing total ... read more

Ñòðàíèöà 5 èç 100

< Previous 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100 Next >